|
ERNA Eterna Therapeutics Inc 748592 |
| Income Statement |
|
Revenue
|
form10-k
|
487,000 |
|
Net Income
|
form10-k
|
-26,604,000 |
|
Profit Margin
|
|
-5462.83% |
| Balance Sheet |
|
Current Assets
|
4,730,000 |
|
Assets
|
7,718,000 |
|
Current Liabilities
|
9,952,000 |
|
Liabilities
|
53,111,000 |
|
Equity
|
-45,393,000 |
|
Shares Out
|
5,411,000 |
| Cash Flow Statement |
|
Operating Cash Flow
|
-12,291,000 |
|
Investing Cash Flow
|
-365,000 |
| Market Analysis |
Market Cap
|
8,007,667 |
|
Price
|
0.26 |
|
BVPS
|
0.02 |
|
PB
|
17.88 |
|
EPS
|
-4.42 |
|
PS
|
4.11 |
|
FCF
|
-12,656,000 |
|
|
Find a discrepancy? The most accurate way to find company fundamental data is to view ERNA documents filed with the SEC.
ERNA Filings
Clear
